Aptevo Therapeutics Inc. (30)

Browse by Contract Category

Contracts

Third Amendment to Credit and Security Agreement dated August 30, 2022 (Filed With SEC on November 10, 2022)
Amendment No. 2 to Rights Agreement, dated as of November 4, 2022, between the Company and Broadridge Corporate Issuer Solutions, Inc., as Rights Agent (Filed With SEC on November 4, 2022)
Ninth Amendment to Office Lease, dated May 26, 2022, by and between Aptevo Therapeutics Inc. and Selig Real Estate Holdings Eight L.L.C (Filed With SEC on August 11, 2022)
Aptevo Therapeutics Inc. Amended and Restated Senior Management Severance Plan (Filed With SEC on March 24, 2022)
Amendment No. 4 to the Collaboration and License Agreement dated as of December 19, 2005 (as previously amended, the Agreement) by and between Emergent Product Development... (Filed With SEC on August 14, 2020)
Limited Consent and Second Amendment to Credit and Security Agreement dated June 7, 2022 (Filed With SEC on August 11, 2022)
Amendment to Royalty Purchase Agreement dated June 7, 2022 (Filed With SEC on August 11, 2022)
Agreement to Terminate Registration Rights Agreement between the Company and Intervac L.L.C. and BioVac L.L.C (Filed With SEC on March 24, 2022)
Registration Rights Agreement, dated February 16, 2022, by and between the Company and Lincoln Park (Filed With SEC on February 17, 2022)
Purchase Agreement, dated February 16, 2022, by and between the Company and Lincoln Park (Filed With SEC on February 17, 2022)
Amendment to Executive Transition Services Agreement (Filed With SEC on November 12, 2021)
Executive Transition Services Agreement (Filed With SEC on November 12, 2021)
Amendment No. 1 to Rights Agreement, dated as of November 5, 2021, between the Company and Broadridge Corporate Issuer Solutions, Inc., as Rights Agent (Filed With SEC on November 5, 2021)
Royalty Purchase Agreement by and among Aptevo Therapeutics Inc. and Healthcare Royalty Partners IV, LP. dated as of March 30, 2021 (Filed With SEC on May 11, 2021)
Description of Capital Stock of Aptevo Therapeutics (Filed With SEC on March 31, 2021)
Equity Distribution Agreement, dated December 14, 2020, between Aptevo Therapeutics Inc. and Piper Sandler & Co (Filed With SEC on December 14, 2020)
Rights Agreement, dated as of November 8, 2020, by and between Aptevo Therapeutics Inc. and Broadridge Corporate Issuer Solutions, Inc., as rights agent (Filed With SEC on November 9, 2020)
Amendment No. 3 to the Collaboration and License Agreement dated as of December 19, 2005 (as previously amended, the Agreement) by and between Emergent Product Development... (Filed With SEC on August 14, 2020)
Amendment No. 2 to the Collaboration and License Agreement dated as of December 19, 2005 (as previously amended, the Agreement) by and between Trubion Pharmaceuticals, Inc.... (Filed With SEC on August 14, 2020)
Amendment No. 1 to the Collaboration and License Agreement dated as of December 19, 2005 (the Agreement) by and between Trubion Pharmaceuticals, Inc. (Trubion) and Wyeth, acting... (Filed With SEC on August 14, 2020)
Collaboration and License Agreement, dated as of December 19, 2005, by and among Wyeth Pharmaceuticals and Trubion Pharmaceuticals, Inc (Filed With SEC on August 14, 2020)
LLC Purchase Agreement by and among Aptevo Therapeutics Inc. and Medexus Pharma, Inc. dated February 28, 2020 (Filed With SEC on March 2, 2020)
Amendment to Lease Dated April 28, 2003 by and between Selig Real Estate Holdings Eight, LLC and later assigned to SREH 2018 Holdings LLC and Aptevo Research and Development LLC (Filed With SEC on November 7, 2019)
Amendment to LLC Purchase Agreement, dated as of August 31, 2017, by and among Aptevo BioTherapeutics LLC, Aptevo Therapeutics Inc., Venus Bio Therapeutics Sub LLC, and Saol... (Filed With SEC on August 9, 2019)
Eighth Amendment to Office Lease, dated as of March 19, 2019, by and between Aptevo Therapeutics Inc. and Selig Real Estate Holdings Eight L.L.C (Filed With SEC on March 22, 2019)
Intellectual Property Security Agreement, dated February 7, 2019, by and amoung, Aptevo Therapeutics Inc., Aptevo Biotherapeutics LLC., Aptevo Research and Development, LLC and... (Filed With SEC on March 18, 2019)
Amendment No. 1 to Amended and Restated Credit and Security Agreement, dated December 14, 2018, by and among, Aptevo Therapeutics Inc., Aptevo Biotherapeutics LLC, Aptevo Research... (Filed With SEC on March 18, 2019)
Form of Pre-Funded Warrant (Filed With SEC on March 11, 2019)
Form of Warrant (Filed With SEC on March 11, 2019)
Underwriting Agreement between Aptevo Therapeutics, Inc. and Piper Jaffray & Co., dated March 7, 2019 (Filed With SEC on March 11, 2019)